GenMark Diagnostics, Inc. ("the Company") on March 15, 2021, the Company entered into an Agreement and Plan of Merger (the Merger Agreement"), dated as of March 12, 2021, with Roche Holdings, Inc. ("Parent") and Geronimo Acquisition Corp., a wholly owned subsidiary of Parent ("Purchaser"). In accordance with the terms of the Merger Agreement, the directors of Purchaser immediately prior to the Effective Time, Bruce Resnick and Sean A. Johnston, became the directors of the Company until the earlier of their resignation or removal or until their respective successors are duly designated, as the case may be, and each of Kevin O'Boyle, Daryl J. Faulkner, James Fox, Lisa Giles, Michael Kagnoff and Scott Mendel voluntarily resigned as directors of the Company.